SFRP4 Is a Potential Biomarker for the Prognosis and Immunotherapy for Gastric Cancer

Figure 5

Association between SFRP4 expression and immune components, including MHC molecules, chemokines, and receptors in patients with stomach adenocarcinoma. (a) Correlation between SFRP4 expression levels and MHC molecules. (b) Relationship between SFRP4 expression levels and chemokines. (c) Correlation between SFRP4 expression levels and receptors.

(a)

(b)

(c)